Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region 26-03-2024, 19:21

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51

Mavenir’s Network Intelligence as a Service AI Agents Deliver 40% Mobility KPI Gains in 5G Non-Standalone Networks 27-02-2025, 20:00